Although there is still a need for more education around the use of biosimilars in cancer, it seems oncologists have become more knowledgeable in the past few years, said Gary H. Lyman, MD, MPH, of Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance.
Although there is still a need for more education around the use of biosimilars in cancer, it seems oncologists have become more knowledgeable in the past few years, said Gary H. Lyman, MD, MPH, of Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance.
Transcript
How comfortable are your peers with using biosimilars to treat patients with cancer? Do you see a need for additional educational activities for prescribers?
There’s absolutely a need for more educational activities and we’re continuing to pursue that both in the medical literature, in reviews, at the major medical meetings, including here at NCCN [National Comprehensive Cancer Network Annual Conference]. It’s imperative.
However, I’ve been doing these education programs probably for the last 3, 3.5 years, and at each one I do see a more educated audience. When I get the questions about the use of biosimilars that are being asked, they’re clearly more familiar with the concepts and they’re asking more subtle and deeper questions. So, I think we are seeing an impact. Again, we’ve gotten NCCN, [the American Society of Clinical Oncology], and the American Society of Hematology all doing large educational programs on these.
And it’s like anything that new: it takes time. And I think over the next 3 to 5 years, I’m anticipating there will be a large-scale impact of biosimilars.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More